home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  April 15, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

Arrayit Corporation

927 Thompson Place
Sunnyvale, 94085 USA
United States of America, California

Phone: 408-744-1331
Fax: 408-744-1711

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: ARYC
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Arrayit Corporation offers the market's most advanced microarray platform for genomics, proteomics, diagnostics and agricultural research. We lead and empower the genetic, research, pharmaceutical and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consummables for disease prevention, treatment and cure.  Our diagnostics pipeline contains pre-symptomatic tests for ovarian cancer (OvaDx®), Parkinson's Disease and prostate cancer, as well as a companion diagnostic for Plavix®.  Arrayit offers the world's finest biomarker discovery platform for the pharmaceutical industry to benchmark the efficacy and safety of blockbuster drugs.  The Arrayit platform is currently installed in 3,800 laboratories worldwide, making Arrayit a leader in the microarray industry.

Selected Categories:
Product Company   Service Company
- Research
- in vitro
- Medical
- Research
- Equipment
- Production

Last update of this entry: July 09, 2019

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.